Crystal structure of the Helicobacter pylori enoyl-acyl carrier protein reductase in complex with hydroxydiphenyl ether compounds, triclosan and diclosan

Proteins: Structure, Function and Genetics

Volumn 69, Issue 3, 2007, Pages 691-694

  Hyung, Ho Lee ^a   Moon, Jinho ^a   Se, Won Suh ^a  

^a Seoul National University   (South Korea)

Author keywords

Antibacterial target; Enoyl ACP reductase; fabI; Helicobacter pylori; Type II fatty acid biosynthesis

Indexed keywords

DICLOSAN; ENOYL ACYL CARRIER PROTEIN REDUCTASE (NADH); ETHER DERIVATIVE; HYDROXYDIPHENYL ETHER; MONOMER; TETRAMER; TRICLOSAN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; COMPLEX FORMATION; CRYSTAL STRUCTURE; ENZYME CONFORMATION; ENZYME SUBSTRATE COMPLEX; HELICOBACTER PYLORI; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

ANTI-BACTERIAL AGENTS; CRYSTALLOGRAPHY, X-RAY; ENOYL-(ACYL-CARRIER-PROTEIN) REDUCTASE (NADH); HELICOBACTER PYLORI; MODELS, MOLECULAR; PHENYL ETHERS; PROTEIN BINDING; PROTEIN CONFORMATION; TRICLOSAN;

HELICOBACTER PYLORI;

EID: 35448938486     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21586     Document Type: Article

References (18)

1. + and a C16 fatty acyl substrate. J Biol Chem 1999;274:15582-15589.
2. Baldock C, Rafferty JB, Sedelnikova SE, Baker PJ, Stuitje AR, Slabas AR, Hawkes TR, Rice DW. A mechanism of drug action revealed by structural studies of enoyl reductase. Science 1996;274:2107-2110.
3. Levy CW, Roujeinikova A, Sedelnikova S, Baker PJ, Stuitje AR, Slabas AR, Rice DW, Rafferty JB. Molecular basis of triclosan activity. Nature 1999;398:383-384.
4. Stewart MJ, Parikh S, Xiao G, Tonge PJ, Kisker C. Structural basis and mechanism of enoyl reductase inhibition by triclosan. J Mol Biol 1999;290:859-865.
5. Qiu X, Janson CA, Court RI, Smyth MG, Payne DJ, Abdel-Meguid SS. Molecular basis for triclosan activity involves a flipping loop in the active site. Protein Sci 1999;8:2529-2532.
6. Rozwarski DA, Grant GA, Barton DH, Jacobs WR Jr, Sacchettini JC. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 1998;279:98-102.
7. Kuo MR, Morbidoni HR, Alland D, Sneddon SF, Gourlie BB, Staveski MM, Leonard M, Gregory JS, Janjigian AD, Yee C, Musser JM, Kreiswirth B, Iwamoto H, Perozzo R, Jacobs WR Jr, Sacchettini JC, Fidock DA. Targeting tuberculosis and malaria through inhibition of enoyl reductase: compound activity and structural data. J Biol Chem 2003;278:20851-20859.
8. Roujeinikova A, Levy CW, Rowsell S, Sedelnikova S, Baker PJ, Minshull CA, Mistry A, Colls JG, Camble R, Stuitje AR, Slabas AR, Rafferty JB, Pauptit RA, Viner R, Rice DW. Crystallographic analysis of triclosan bound to enoyl reductase. J Mol Biol 1999;294:527-535.
9. Suguna K, Surolia A, Surolia N. Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum. Biochem Biophys Res Commun 2001;283:224-228.
10. Perozzo R, Kuo M, Sidhu AS, Valiyaveettil JT, Bittman R, Jacobs WR Jr, Fidock DA, Sacchettini JC. Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase. J Biol Chem 2002;277:13106-13114.
11. Pidugu LS, Kapoor M, Surolia N, Surolia A, Suguna K. Structural basis for the variation in triclosan affinity to enoyl reductases. J Mol Biol 2004;343:147-155.
12. Bhargava HN, Leonard PA. Triclosan: applications and safety. Am J Infect Control 1996;24:209-218.
13. Veldhoen N, Skirrow RC, Osachoff H, Wigmore H, Clapson DJ, Gunderson MP, Van Aggelen G, Helbing CC. The bactericidal agent triclosan modulates thyroid hormone-associated gene expression and disrupts postembryonic anuran development. Aquat Toxicol 2006;80:217-227.
14. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999;284:1328-1333.
15. Lee HH, Yun J, Moon J, Han BW, Lee BI, Lee JY, Suh SW. Crystallization and preliminary X-ray crystallographic analysis of enoyl-acyl carrier protein reductase from Helicobacter pylori. Acta Crystallogr D Biol Crystallogr 2002;58:1071-1073.
16. Brünger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 1998;54:905-921.
17. Jones TA, Zou JY, Cowan SW, Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr Sect A 1991;47:110-119.
18. Chhibber M, Kumar G, Parasuraman P, Ramya TN, Surolia N, Surolia A. Novel diphenyl ethers: design, docking studies, synthesis and inhibition of enoyl ACP reductase of Plasmodium falciparum and Escherichia coli. Bioorg Med Chem 2006;14:8086-8098.